STAGE IIIB BREAST CANCER AJCC V7
Clinical trials for STAGE IIIB BREAST CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB BREAST CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIB BREAST CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test One-Two punch against tough breast cancers
Disease control OngoingThis early-stage study is testing a new combination of two drugs, veliparib and carboplatin, for people with advanced HER2-negative breast cancer that has spread. The main goals are to find the safest and most effective dose and to understand the side effects. Researchers hope th…
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Can diet, exercise, and stress relief help beat breast cancer?
Disease control OngoingThis study is testing whether a comprehensive lifestyle program can improve outcomes for people with stage II or III breast cancer who are undergoing radiation therapy. The program includes dietary coaching, exercise, stress management, and social support. Researchers want to see…
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Early trial tests new drug mixes for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial aims to find safe doses and understand side effects of several drug combinations for patients with advanced cancers that haven't responded to standard treatments. The study involves 155 participants with various advanced or metastatic cancers and some rare …
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test new drug duo to starve and stop advanced cancers
Disease control OngoingThis study is testing whether taking two oral drugs, cediranib and olaparib, together can help control advanced cancers that have spread or cannot be surgically removed. It is for adults with specific types of advanced lung, breast, or pancreatic cancer who have already tried at …
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Scientists test new drug duo in fight against spreading breast cancer
Disease control OngoingThis early-stage trial is testing a combination of two drugs, cyclophosphamide and veliparib, for people with advanced breast cancer that has spread. The main goal is to find the safest and most effective dose of this drug pair. Researchers will also check if certain markers in a…
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Gene test spares thousands from unnecessary chemo
Disease control OngoingThis large study aimed to find the best treatment for women with a common type of early-stage breast cancer. It used a special gene test (Oncotype DX) to see if hormone therapy alone was just as good as hormone therapy plus chemotherapy for women with a mid-range test score. The …
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
New drug challenge to standard breast cancer treatment
Disease control OngoingThis study is testing whether a newer hormone therapy drug called Z-Endoxifen works better than the standard drug tamoxifen for controlling advanced breast cancer. It involves 81 postmenopausal women whose cancer has spread, is fueled by estrogen, and has stopped responding to in…
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
Needles vs. pain: can ancient practice ease cancer Survivors' suffering?
Symptom relief OngoingThis study is testing whether a form of acupuncture using mild electrical pulses can help reduce long-term pain in women who have been treated for early-stage breast cancer. It involves 111 participants who are randomly assigned to receive either real electroacupuncture, a fake v…
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 16, 2026 15:25 UTC